Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Normalization in Epilepsy with Hyponatremia
NCT03371199Completed
- Sponsor
- Rigshospitalet
- Start
- Dec 2017
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Randomised, single-blind trial of sodium chloride in hyponatremia (2 arms), sponsored by Rigshospitalet. Primary endpoint: CTX1 change at 4 months. Started Dec 2017; status: completed.
02
Drugs
sodium chloride
03
Conditions
hyponatremia
Beyond the preview
Go deeper on NCT03371199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03371199.